Ceragenix Wins Dismissal Of Ex-Exec's SOX Complaint
Law360, New York (August 12, 2016, 4:50 PM EDT) -- A former executive for a bankrupt medical device company lost a $10 million defamation and retaliation suit against his former employer Thursday when a Colorado federal judge found that his actions weren’t protected under the Sarbanes-Oxley Act and that he wasn’t defamed.
U.S. District Judge Wiley Y. Daniel granted ex-Ceragenix Pharmaceuticals CEO Steven S. Porter’s motion for summary judgment against Carl Genberg, the company’s one-time vice president of research and development, who was fired for allegedly providing important private company information to outsiders. Genberg had claimed that Sarbanes-Oxley protected his conduct and that Porter defamed him after his termination by calling...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!